Hyderabad, Mar 23(TNT): Sai Parenterals Limited has raised ₹122.64 crore from anchor investors ahead of its proposed Initial Public Offering (IPO). The Hyderabad-based pharma company allocated 31,28,485 equity shares to anchor investors at ₹392 per share, following approval by its IPO Committee in consultation with […….]
Mumbai, Mar 21 (TNT): Glenmark Pharmaceuticals on Saturday launched GLIPIQⓇ (semaglutide) in India for the treatment of Type 2 Diabetes Mellitus, positioning it as an affordable option in the GLP-1 therapy segment. In a release, the company said the product sets a new benchmark in […….]
Hyderabad, Mar 21 (TNT): Dr. Reddy’s Laboratories on Saturday announced the launch of its injectable semaglutide, branded as Obeda®, marking India’s first generic version approved by the Drugs Controller General of India (DCGI) for the treatment of Type 2 diabetes. In a release, the Hyderabad […….]
New Delhi, Mar 18 (TNT): Mankind Pharma Limited on Wednesday announced the acquisition of the Rivotril brand from Roche for the Indian market, securing exclusive rights to manufacture, market and distribute the product across the country. Rivotril, the innovator brand of clonazepam, is widely prescribed […….]
Chennai, Mar 17 (TNT): Agilisium on Tuesday announced an investment of ₹50 crore (about $5.5 million) to transform how life sciences enterprises operationalise artificial intelligence (AI), introducing a new category of professionals termed Forward Deployment Experts (FDX). The company said the initiative aims to bridge the […….]
Mumbai, Mar 17 (TNT): Lupin Limited on Tuesday said it has entered into a licensing and supply agreement with Zydus Lifesciences Limited to co-market semaglutide injection in India for the treatment of diabetes and related metabolic disorders. Under the agreement, Lupin will have semi-exclusive rights to […….]
Hyderabad, Mar 17 (TNT): SAI Parenteral’s Limited on Tuesday announced it has filed its Red Herring Prospectus (RHP) with the Registrar of Companies, Hyderabad, the Securities and Exchange Board of India (SEBI) and stock exchanges for its proposed Initial Public Offering (IPO). The IPO comprises a […….]
Hyderabad, Mar 15 (TNT): Dr. Reddy’s Laboratories on Sunday hosted the fourth edition of the Dr. Anji Reddy Memorial Lecture, underscoring the importance of advancing scientific research to address future healthcare challenges. The annual lecture series was instituted in 2023 to honour the memory of the […….]
Hyderabad, Mar 14 (TNT): US-based Cambridge Isotope Laboratories (CIL) and Hyderabad-based Chemtatva Chiral Solutions Pvt Ltd , on Saturday announced a strategic joint venture to establish advanced manufacturing facilities in Telangana with an investment of up to ₹300 crore over the next three years. The […….]
Hyderabad, Mar 13 (TNT): The Maharashtra Industrial Development Corporation (MIDC) has signed a concession agreement with Maha Integrated Life Sciences City Limited (MILeS City), a wholly owned subsidiary of Ramky Infrastructure Limited, to develop a high-tech pharmaceutical park at the Dighi Port Industrial Area in […….]
Copyright © 2026 | WordPress Theme by MH Themes